From the laboratory to the investment fund
From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is helping salmon and ham producers
From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is helping salmon and ham producers
Biotech: A Big Future Behind It? Despite a bumpy 2004, the rush to market hasn’t abated. The key for this crop of newcomers: Holding investors’ attention?
The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan
The Human Genome, Take Two When a sequenced human genome was announced in 2001, most people missed a crucial part of the news: the genome was a first draft, sketchy and incomplete. This fall, scientists completed a new draft. The more complete version reveals that humans have a few thousand fewer genes than was previously […]
Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their germs could spread to smaller, hotter biotech stocks.
Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their germs could spread to smaller, hotter biotech stocks.
Financial Snapshot For December Financial Snapshot For December 2004: Sideways
Facing Biotech Foods Without the Fear Factor “Almost everywhere food is sold these days, you are likely to find products claiming to contain no genetically modified substances. But unless you are buying wild mushrooms, game, berries or fish, that statement is untrue.”
Big Changes for Big Pharma Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are six trends that will alter the industry in 2005
Biotechs forced to work harder to fill openings: Bay Area biotech companies are scrambling to attract and retain both researchers and executives in a cut-throat national and even international job market.